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London, UKAbstract—Genetic background is known to inﬂuence the
outcome in mouse models of human disease, and previous
experimental studies have shown strain variability in the
neonatal mouse model of hypoxia–ischemia. To further
map out this variability, we compared ﬁve commonly used
mouse strains: C57BL/6, 129SVJ, BALB/c, CD1 and FVB in
a pure hypoxic–ischemic setup and following pre-
sensitization with lipopolysaccharide (LPS). Postnatal
day 7 pups were subjected to unilateral carotid artery occlu-
sion followed by continuous 30 min 8% oxygen exposure at
36 C. Twelve hours prior, a third of the pups received a sin-
gle intraperitoneal LPS (0.6 lg/g) or a saline (vehicle) admin-
istration, respectively; a further third underwent hypoxia–
ischemia alone without preceding injection. Both C57BL/6
and 129SVJ strains showed minimal response to 30 min
hypoxia–ischemia alone, BALB/c demonstrated a moderate
response, and both CD1 and FVB revealed the highest brain
damage. LPS pre-sensitization led to substantial increase in
overall brain infarction, microglial and astrocyte response
and cell death in four of the ﬁve strains, with exception of
BALB/c that only showed a signiﬁcant eﬀect with terminal
deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL). Saline administration prior to hypoxia–ischemia
resulted in an increase in inﬂammatory-associated markers,
particularly in the astroglial activation of C57BL/6 mice, and
in combined microglial activation and neuronal cell loss in
FVB mice. Finally, two of the four strongly aﬀected strains
– C57BL/6 and CD1 – revealed pronounced contralateral
astrogliosis with a neuroanatomical localization similar to
that observed on the occluded hemisphere. Overall, the
current ﬁndings demonstrate strain diﬀerences in response
to hypoxia–ischemia alone, to stress associated with vehi-
cle injection, and to LPS-mediated pre-sensitization, which
partially explains the high variability seen in the neonatalhttp://dx.doi.org/10.1016/j.neuroscience.2015.10.035
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292mouse models of hypoxia–ischemia. These results can be
useful in future studies of fetal/neonatal response to inﬂam-
mation and reduced oxygen–blood supply.  2015 The
Authors. Published by Elsevier Ltd. on behalf of IBRO. This
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ischemia.INTRODUCTION
The postnatal day 7 mouse model of hypoxic–ischemic
insult is widely used as a model of neuropathology that
mimics, to a certain degree, the pathology of hypoxic–
ischemic injury occurring in human late-preterm to term
neonates (Sheldon et al., 1998; Clancy et al., 2001, 2007).
With the addition of transgenicmice, thismodel has become
particularly relevant inestablishing thegenetic basisof injury
evolution and assessing eﬃcacy of experimental treat-
ments. As clinical advances have shown perinatal brain
damage to be multifactorial, the neonatal mouse model of
hypoxia–ischemia encephalopathy has also been modiﬁed
to include not just hypoxia–ischemia, but also an infection/i
nﬂammation-sensitizing element, known to exacerbate
some human cases of perinatal brain damage (Eklind
et al., 2001; Wu et al., 2003; Aly et al., 2006).
Previous research have shown that the strain
background inﬂuences the degree of brain damage in
neonatal mouse models of hypoxic (Li et al., 2008,
2009, 2013), ischemic (Comi et al., 2009) and hypoxic–is-
chemic (Sheldon et al., 1998) insults. Additionally, studies
looking at inﬂammatory response in diﬀerent mouse
strains demonstrated that strain background plays a role
in cytokine synthesis (Lambertsen et al., 2002; Hoover-
Plow et al., 2008; Gibb et al., 2011; Browne et al., 2012)
as well as inﬂammatory cell recruitment (White et al.,
2002; Hoover-Plow et al., 2008). However, to our knowl-
edge, no study to date has investigated whether this
strain-mediated variation in response to injury is also seen
in the synergistic model of inﬂammation and neonatal
hypoxia–ischemia.
Addressing the variability in strain-mediated response
to brain injury is paramount to improve understanding of
the pathways and mechanisms involved in perinatal
brain damage. In the current study, we have therefore
used ﬁve diﬀerent mouse strains – C57BL/6, 129SVJ,/licenses/by/4.0/).
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or as source of transgenic animals – to investigate the
eﬀects of strain background in the mediating
vulnerability or resistance to both hypoxia–ischemia
alone and in endotoxin-mediated hypoxia–ischemia
injury. For the latter, we used the well-established
lipopolysaccharide (LPS) pre-sensitization to
subsequent hypoxia–ischemia injury model (Hagberg
et al., 2002; Wang et al., 2009; Kendall et al., 2011;
Lange et al., 2014).
EXPERIMENTAL PROCEDURES
Animals
All animal experiments were carried out in accordance
with the UK Animals (Scientiﬁc Procedures) Act 1986
and approved by the Home Oﬃce. The several lines of
wild type mice used in this study: C57BL/6, 129SVJ,
BALB/c, CD1 and FVB, were sourced from Charles
River, UK. The ARRIVE guidelines were followed. All
ﬁve diﬀerent background strains were bred
simultaneously, and experimental procedures carried
out around the same period of time.
Hypoxia–ischemia surgery and endotoxin
Postnatal day 7 mice were anesthetized with isoﬂurane
(5% induction, 1.5% maintenance). The left common
carotid artery was permanently ligated with 8/0
polypropylene suture and the incision closed using tissue
glue. Pups were allowed to recover at 36 C and
returned to respective dams to nurse for 1.5 h before
being placed in a sealed hypoxic chamber and exposed
to a constant ﬂow of humidiﬁed 8% oxygen/92% nitrogen
at 36 C for 30 min. After 10 min recovery at 36 C, the
mice were returned to their dams. 12 h prior, pups were
randomly allocated to receive a single intraperitoneal
injection of 0.6 lg/g LPS (Escherichia coli, serotype 055:
B5; Fluka, UK), 0.9% sterile normal saline, or no
treatment. All three experimental groups – HI alone, HI
+ SAL, HI + LPS – were performed simultaneously,
ensuring all three groups contained littermates.
Histochemistry and immunohistochemistry
Forty-eight hours after hypoxia–ischemia, animals were
terminally anesthetized using pentobarbital sodium.
Additionally, naı¨ve animals (no surgery/hypoxia/injection,
n=3 per strain) were also perfused at P9 for brain
histology. Paw withdrawal reﬂex was used to determine
extent of anesthesia, before transcardial perfusion with 4%
paraformaldehyde (PFA) in 0.1 M phosphate buﬀer (PB).
Brains were extracted and post-ﬁxed in 4% PFA/PB on a
rotator for 1 h, followed by overnight rotation immersion in
30% sucrose for cryoprotection. The forebrains were frozen
on dry ice and sectioned using a cryostat. Fifty sequential
coronal sections of 40-lm thickness, starting from the
fusion point of the corpus callosum, were collected onto
0.5% gelatinised glass slides and stored at 80 C.
Tissue samples were stained as previously described
(Hristova et al., 2010). In brief, brain sections were
rehydrated in bidistilled water and spread ﬂat onto theslide under a dissection microscope. After fan drying for
10 min, sections were ﬁxed 5 min in 4% PFA and trans-
ferred into 0.1 M PB, treated with acetone (50%, 100%,
50%), washed twice in 0.1 M PB, and once in 0.1% bovine
serum albumin (BSA)/0.1 M PB.
For immunohistochemistry, sections were blocked in
5% goat serum (Sigma, Gillingham, Dorset, UK) in PB for
30 min, and incubated with alphaM (amb2 integrin;
1:5000; Serotec, Kidlington, Oxford, UK) or glial ﬁbrillary
acidic protein (GFAP; 1:6000; DAKO, Ely,
Cambridgeshire, UK) overnight at 4 C. Both alphaM and
GFAP immunostainings routinely included 2–3 negative
control sections where respective primary antibody was
absent. Sections were washed by serial immersions in
PB/BSA, PB, PB and PB/BSA. The appropriate
biotinylated secondary antibody (anti-rat or anti-rabbit)
was pre-incubated with mouse serum (1:50; Serotec,
Kidlington, Oxford, UK) for 30 min at 37 C before being
diluted to 1:100 in PB/BSA and sections incubated for 1 h
at room temperature, washed twice in PB/BSA and PB,
incubated for 1 h with avidin–biotinylated horse radish
peroxidase Complex (ABC; 1:100; Vector, Peterborough,
UK) solution, washed in four changes of 10 mM PB and
visualized with diaminobenzidine (DAB; Sigma,
Gillingham, Dorset, UK) in hydrogen peroxide (Sigma,
Gillingham, Dorset, UK). Reaction was stopped in
10 mM PB and washed twice in bidistilled water. Slides
were dehydrated by consecutive 2 min immersion in
increasing concentrations of ethanol (70%, 90%, 100%),
isopropanol, 3 times xylene, and covered using DEPEX.
For terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) assay, sections were incubated in
3% hydrogen peroxide in methanol (15 min), and washed
in 0.1 M PB. Slides were then incubated with terminal
deoxytransferase (TdT) and deoxyuridine triphosphate
(dUTP) solution (0.1% TdT, 0.15% dUTP, 1% cacodylate
buﬀer; Roche, Welwyn Garden City, Hertfordshire, UK)
for 2 h at 37 C. The reaction was stopped in TUNEL stop
solution (300 mM NaCl, 300 mM Sodium Citrate) for
10 min. Slides were washed in 3  0.1 M PB, incubated
in ABC solution (1 h at room temperature), washed 4
times in 10 mM PB and visualized using DAB enhanced
with cobalt nickel in the presence of hydrogen peroxide.
Reaction was stopped as described above.
Sections used for Nissl staining were ﬁxed overnight in
4% PFA followed by 70% ethanol overnight. On day 3
sections were immersed in Cresyl Violet solution (BDH,
East Grinstead, West Sussex, UK) for 3 min, followed by
immersion in consecutive ethanol dehydration (70%,
90%, 96%, 96% with acetic acid, 100%), isopropanol and
three washes in xylene before being covered in DEPEX.
Histological assessment
Each histological assessment was performed on ﬁve
sections 400 lm apart. Infarct size was measured using
Optimas 6.5 image software, and the intact areas of the
isocortex, pyriform cortex, hippocampus, striatum, thalamus
and external capsule white matter were delineated
bilaterally and measured as described previously (Kendall
et al., 2012). Injury score (see Table 1) based on combined
microglial activation (aM immunoreactivity) and neuronal cell
Table 1. Brain injury score assessment
Score alphaM immunoreactivity
0 No microglial activation
1 Focal activation
2 Mild diﬀuse activation, occasional ameboid
macrophages present
3 Widespread activation, predominant ameboid
macrophages present
4 Tissue loss
Score Nissl (Cresyl Violet) staining
0 No damage
1 Minimal evidence of damage with no discernible infarct
2 Small infarct (<50%) of the aﬀected brain region
3 Large infarct (>50%) of the aﬀected brain region
4 Total neuronal cell loss
Brain injury score. There is a direct correlation between the level of microglial
activation and neuronal cell loss (adapted from (Kendall et al., 2006)).
294 E. Rocha-Ferreira et al. / Neuroscience 311 (2015) 292–307loss (Nissl stain) was assessed in the same aforementioned
brain regions and adapted from a scoring system previously
established in our laboratory (Kendall et al., 2006). The
presence of cell death involving DNA fragmentation was
detected through quantiﬁcation of the number of TUNEL
positive nuclei in three separate ﬁelds (20 magniﬁcation)
per assessed brain region. Mean and standard deviation of
optical luminosity values were measured in three ﬁelds
(20 magniﬁcation) of the diﬀerent brain regions of GFAP-
stained slides using Optimas 6.5 image software (Kendall
et al., 2011).All assessmentswereperformedbyanobserver
blinded to the diﬀerent treatments. Additionally, each assess-
ment was performed for each of the strains simultaneously.Statistical analysis
Average ± standard error of the mean (SEM) was
recorded for all data. Statistical analysis for infarct size,
alphaM immunoreactivity and neuronal loss, TUNEL+
counts and GFAP luminosity between ipsilateral and
contralateral brain hemispheres of all three diﬀerent
groups was initially tested for normal distribution. As the
data did not follow the Gaussian distribution, the
diﬀerent assessments were performed using Kruskal–
Wallis one-way analysis followed by Dunn multiple
comparison test in PRISM GraphPad 6. Interstrain
variations in response to HI alone, HI + SAL and HI
+ LPS were assessed for heterogeneity in meta-
analysis using Chi-Squared test. p< 0.05 was
considered to represent a signiﬁcant diﬀerence between
groups. In order to achieve the necessary statistical
power, and based on previous studies performed in our
group (Kendall et al., 2011; Lange et al., 2014), the size
of the groups was adjusted to n= 10.RESULTS
In the current study we used a combination of two
diﬀerent established models of neonatal mouse
hypoxic–ischemic injury, known to generate ipsilateral
brain damage in rats (Rice et al., 1981) and mice
(Hagberg et al., 2004; Wang et al., 2009): (i) hypoxia–
ischemia (HI) alone, where postnatal day 7 animalsunderwent unilateral left carotid artery occlusion followed
by 30 min continuous 8% oxygen exposure at 36 C,
shown previously in our group to generate mild but
deﬁnite ipsilateral damage in the C57BL/6 mouse strain
(Kendall et al., 2011); and (ii) synergistic infection
/inﬂammation and hypoxia–ischemia injury, using LPS
pre-sensitization to subsequent hypoxia–ischemia, where
LPS administration 12 h prior to hypoxia–ischemia insult
is known to induce a robust pre-sensitization eﬀect in
the C57BL/6 mouse strain (Kendall et al., 2011; Lange
et al., 2014). Saline (vehicle) pre-treatment was used as
control for LPS administration, and untouched littermates
prior to hypoxic–ischemic insult as control for any
pre-hypoxia–ischemia intervention.
Infarct volume
The micrographs shown in Fig. 1A demonstrate a robust
LPS-mediated sensitization to hypoxia–ischemia
compared to saline-injected controls. This increase
reached signiﬁcance in the ipsilateral brain hemisphere
of four of the ﬁve assessed strains (C57BL/6, 129SVJ,
CD1, FVB), but not for the BALB/c mice. C57BL/6
(p< 0.01), CD1 (p< 0.001) and FVB (p< 0.01)
animals demonstrated the largest increase (Fig. 1B, C),
with all assessed brain regions signiﬁcantly aﬀected,
including isocortex (Fig. 1D): C57BL/6 (p< 0.01), CD1
(p< 0.001) and FVB (p< 0.01); pyriform cortex
(Fig. 1E): C57BL/6 (p< 0.05), CD1 (p< 0.01) and FVB
(p< 0 .01), hippocampus (Fig. 1F): C57BL/6 (p< 0.01),
CD1 (p< 0.01) and FVB (p< 0.05), striatum (Fig. 1G):
C57BL/6 (p< 0.01), CD1 (p< 0.001) and FVB
(p< 0.01), thalamus (Fig. 1H): C57BL/6 (p< 0.01),
CD1 (p< 0.05) and FVB (p< 0.05); and external
capsule white matter (Fig. 1I): C57BL/6 (p< 0.01), CD1
(p< 0.001) and FVB (p< 0.01). 129SVJ animals had a
signiﬁcant increase in tissue infarction in four out of the
six individual brain regions (Fig. 1D–E, G, I): isocortex
(p< 0.05), pyriform cortex (p< 0.01), striatum
(p< 0.05) and external capsule (p< 0.05), which also
resulted in an overall signiﬁcant increase in brain
damage shown in Fig. 1B, C (p< 0.01).
LPS pre-treated mice also revealed a signiﬁcant
overall increase in tissue infarction when compared to
the hypoxia–ischemia alone group in the C57BL/6
(p< 0.05), 129SVJ (p< 0.01), CD1 (p< 0.05) and
FVB (p< 0.01) strains. This eﬀect was signiﬁcant in all
assessed brain regions across the C57BL/6, 129SVJ,
CD1, and FVB strains except for the C57BL/6 thalamus
(Fig. 1C–I). As with the HI + LPS vs. HI + SAL
comparison, there was no signiﬁcant increase in tissue
infarction in LPS-injected BALB/c animals compared to
hypoxia–ischemia alone.
Infarct volume: treatment and interstrain eﬀects. Over-
all, of the 35 comparisons possible in Fig. 1C–H, i.e. ﬁve
strains  (six regional + one total tissue loss), there
were 27 instances of signiﬁcant increase for HI + LPS
vs. HI + SAL (27/35, highlighted with *), and same
number for the HI + LPS vs. HI alone comparison
(27/35, highlighted with §). In each of the ﬁve
diﬀerent strains, saline administration alone prior to
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overall infarction, for individual regions (Fig. 1D–H) as
well as for the whole forebrain (Fig. 1B): C57BL/6
(p= 0.397), 129SVJ (p= 0.7019), BALB/c
(p= 0.2354), CD1 (p= 0.6923) and FVB (p= 0.4033).
HI alone. Total tissue infarction in CD1 (p< 0.01) and
FVB (p< 0.01) strains was signiﬁcantly larger than in
129SVJ animals (Fig. 1C). Regionally (Fig. 1D–I), this
also applied to the striatum (p< 0.05 and p< 0.01,
respectively), thalamus (p< 0.001 and p< 0.05) and
external capsule (p< 0.05 and p< 0.01). CD1 animals
also had higher tissue loss vs. 129SVJ in the isocortex
(p< 0.05) and hippocampus (p< 0.05).
HI + SAL. FVB animals revealed a higher total tissue
loss compared to C57BL/6 (p< 0.05) and 129SVJ
(p< 0.01) strains. This was also true for the isocortex
(p< 0.01 and p< 0.01) and striatum (p< 0.05 and
p< 0.01). Compared to just 129SVJ, this also applied
to the hippocampus (p< 0.05) and external capsule
(p< 0.05). In the case of CD1 vs. 129SVJ, CD1
animals had signiﬁcantly more infarction in the striatum
and hippocampus (p< 0.05).
HI + LPS. Total tissue infarction in CD1 and FVB
strains was signiﬁcantly larger than in the C57BL/6
(p< 0.01 and p< 0.01, respectively), 129SVJ
(p< 0.01 and p< 0.001, respectively) and BALB/c
(p< 0.05 and p< 0.05, respectively). In all assessed
regions, FVB again appeared to be the strain with the
strongest infarction vs. C57BL/6, 129SVJ, and BALB/c.
Interstrain meta-analysis. Across all graphs in
Fig. 1C–I, signiﬁcant interstrain diﬀerences were only
observed between two strain subgroups, in all three
treatments (HI alone, HI + SAL, HI + LPS) – with CD1
and FVB in one, and 129SVJ, C57BL/6 and BALB/c in
the other subgroup. Generally, the number of signiﬁcant
interstrain diﬀerences strongly varied with treatment – HI
alone was associated with a total of 10 signiﬁcant
comparisons at 0.05 level out of possible 42 across
Fig. 1C–I. The number of possible comparisons was
calculated as 42 (=2 * 3 * 7), with two standing for the
number of subgroup A strains, three for the number of
subgroup B strains and seven for the number of3
Fig. 1. Pre-treatment with LPS 12 h prior to hypoxia–ischemia in postnata
diﬀerent mouse strains. (A) Nissl staining of mouse forebrains of C57BL/6, 12
Coronal hemisphere sections (40 lm) at the level of the cortex and beginning
second row mice exposed to hypoxic–ischemic insult alone (HI alone), third
with pre-treatment of 0.6 lg LPS/g body weight (HI + LPS). (B, C) Infarct volu
(C). (D–I) Individual forebrain regions in isocortex (D), pyriform cortex (F), hip
percentage of that region on the contralateral hemisphere. Just minimal tiss
+ SAL groups in the mouse strains of C57BL/6 (n= 10 and 11 animals, res
BALB/c (11/9), CD1 (10/12) and FVB (9/11). LPS pre-treatment strongly sensi
6 (n= 11), 129SVJ (n= 10), CD1 (n= 10) and FVB (n= 11) LPS-treated a
animals. BALB/c mice (n= 10) did not show signiﬁcantly increased LPS-me
hypoxia–ischemia, Saline administration revealed no eﬀect overall (B–I). p<
comparison test (*for HI + LPS vs. HI + SAL, §for HI + LPS vs. HI alone,
comparison). Bar scale = 1.2 mm.diﬀerent brain regions tested (including the total brain
volume loss). HI + SAL was associated with 11 out of
42 and HI + LPS with 26 out of 42. In other words, in
the case of brain tissue volume loss, the overall number
of signiﬁcant strain diﬀerences did not change with
saline pre-treatment, but increased with LPS
sensitization compared against HI alone (p< 0.001 in
Chi-Square test in a 2  3 matrix, followed by the
individual 2  2 comparison), as well as against HI
+ SAL (p< 0.001).
In terms of 129SVJ, C57BL/6 and BALB/c, compared
with subgroup B strains, there were 30 signiﬁcant
diﬀerences at 0.05 level (out of 42 possible) for 129SVJ,
12/42 for C57BL/6 and 5/42 for BALB/c. Overall,
129SVJ displayed a signiﬁcantly higher number of
diﬀerences vs. FVB and CD1 than for C57BL/6 or
BALB/c (p< 0.001 for either, as above). Diﬀerences for
C57BL/6 vs. BALB/c did not reach signiﬁcance level
(p= 0.057 in Chi-Square test). In terms of CD1 and
FVB, compared with subgroup A strains, there were 22
signiﬁcant diﬀerences (out of 63 possible) for CD1 and
25/63 for FVB, these diﬀerences were not signiﬁcantly
diﬀerent in Chi-Square test (p= 58%). Generally, in
terms of extent of tissue loss, current data meta-
analysis for extent of brain volume loss would thus
suggest HI < HI + SAL <<HI + LPS for treatment,
and 129SVJ < C57BL/6 << BALB/c << CD1< FVB
for the aﬀected mouse strain.Injury score
In addition to tissue loss, LPS pre-treatment is known to
signiﬁcantly increase ipsilateral microglial activation and
neuronal cell loss, which are scored blindly and then
combined in the brain injury score (Kendall et al., 2011).
Fig. 2A gives an overview of the eﬀects of LPS sensitiza-
tion on microglial activation following hypoxic–ischemic
insult in the current study, the eﬀects on the brain injury
score are shown in Fig. 2B–I. Compared with the saline
controls, the highest overall increase following LPS sensi-
tization was observed in the C57BL/6 background, where
all assessed brain regions (Fig. 2D–I) as well as their
overall average (Fig. 2B, C) showed a signiﬁcant increase
in injury score: isocortex (p< 0.001), pyriform cortex
(p< 0.01), hippocampus (p< 0.01), striatum
(p< 0.05), thalamus (p< 0.05) and external capsulel day 7 mice normally results in augmented brain infarction across
9SVJ, BALB/c, CD1 and FVB strains 48 h following hypoxia–ischemia.
of the hippocampus; the upper row shows untreated naı¨ve animals,
row those injected 12 h earlier with saline (HI + SAL), and lower row
me assessment of overall tissue loss per strain (B) and per treatment
pocampus (H), striatum (E), thalamus (G) and external capsule (I) as
ue loss was observed in 30 min hypoxia–ischemia alone and the HI
pectively) and 129SVJ (10/10), but this increased, moderately, in the
tized to hypoxia–ischemia insult, with statistical signiﬁcance in C57BL/
nimals when compared to the saline-injected controls and to HI alone
diated tissue infarction. Compared with animals not injected prior to
0.05 for Kruskal–Wallis one-way analysis, followed by Dunn multiple
#for HI + SAL vs. HI alone, overhead bar for interstrain treatment
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most aﬀected, with a signiﬁcant increase in all regions
except external capsule: isocortex (p< 0.05), pyriform
cortex (p< 0.05), hippocampus (p< 0.05), striatum
(p< 0.05) and thalamus (p< 0.05) (Fig. 2D–H). In CD1
animals the pyriform cortex (p< 0.05), hippocampus
(p< 0.05), striatum (p< 0.05) and thalamus (p< 0.05)
were also signiﬁcantly aﬀected (Fig. 2E–H), 129SVJ
LPS-treated animals only showed a substantial increase
(p< 0.05) in the isocortex (Fig. 2B).
Brain injury score: treatment and interstrain meta-
analysis. Unlike the tissue loss in Fig. 1, the injury score
comparison between HI + LPS and HI alone revealed a
more extensive eﬀect than that observed for HI + LPS
vs. HI + SAL. Signiﬁcant increases (p< 0.05) were
now also present for the BALB/c strain (Fig. 2C–H), with
the external capsule being the only exception (Fig. 2I).
Overall, there were 31 instances (out of 35 possible)
of signiﬁcant increase for HI + LPS vs. HI alone,
compared to 20/35 for HI + LPS vs. HI + SAL
comparison (p< 0.01 in Chi-Square test). BALB/c
eﬀects (n= 6) contributed to roughly half of the
increase in the overall number of signiﬁcant changes for
HI + LPS vs. HI alone (n= 11). In a similar vein, the
FVB strain also showed a signiﬁcant, saline injection-
associated increase in injury score compared with
hypoxia–ischemia alone across the entire ipsilateral
forebrain hemisphere. This eﬀect was observed overall
(Fig. 2C), but also regionally, in pyriform cortex,
hippocampus, striatum and external capsule (Fig. 2E–G,
I). Generally, there was little evidence of brain injury in
the contralateral hemisphere in any of the ﬁve strains,
irrespective of the type of insult (data not shown).
As with tissue volume loss, with the exception of the
BALB/c external capsule (Fig. 2I), signiﬁcant interstrain
diﬀerences for injury score were only observed between
the two strain subgroups, in all three treatments (HI
alone, HI + SAL, HI + LPS) – with CD1 and FVB in
one, and 129SVJ, C57BL/6 and BALB/c in the other
subgroup. In the B strain subgroup, there was again no
signiﬁcant diﬀerence in the number of signiﬁcant
comparisons for CD1 (16/63) and for FVB (23/63). In
the A subgroup, 129SVJ displayed a signiﬁcantly higher
number of diﬀerences vs. FVB and CD1 (31/42), than
for C57BL/6 (6/42) or BALB/c (2/42) (p< 0.001 for
either, as above). Diﬀerences for C57BL/6 vs. BALB/c
did not reach signiﬁcance level (p= 0.137).3
Fig. 2. LPS sensitization to neonatal hypoxia–ischemia substantially increase
CD1 and FVB background. (A) Microglial activation staining (alphaM) of coron
strains 48 h following hypoxia–ischemia. The upper row shows untreated n
insult alone (HI alone), third row those injected 12 h earlier with saline (HI + S
(HI + LPS). Nissl staining used for neuronal cell loss scoring is shown in Fig
treated BALB/c strain showed minimal increase in microglial activation and ne
comparison with HI alone animals revealed a signiﬁcant increase in combine
ischemia, Saline administration elicited an increase in injury score overall (B
treatment comparison revealed that both CD1 and FVB background strains h
reached when compared to 129SVJ animals (C–I). p< 0.05 for Kruskal–Wa
HI + LPS vs. HI + SAL, §for HI + LPS vs. HI alone, #for HI + SAL vs.
scale = 0.5 mm.In terms of treatment – HI alone was associated with a
total of eight signiﬁcant comparisons at 0.05 level out of
possible 42 across Fig. 1C–I. HI + SAL with was
associated with 15 out of 42 and HI + LPS with 16 out
of 42. Data suggested that pre-treatment per se would
be associated with a signiﬁcantly higher number of
strong diﬀerences between strains, but this did not
reach signiﬁcance (p= 0.120 in the initial Chi-Square
test in a 2  3 matrix).TUNEL+ cells
Results in Figs. 1 and 2 demonstrate that LPS
administration prior to hypoxic–ischemic insult has a
signiﬁcant detrimental eﬀect within the ﬁrst 48 h.
Hypoxia–ischemia is associated with a rapid increase in
neural cell death- as shown in Fig. 3A; this is also
conﬁrmed by TUNEL histochemistry for nuclear
fragmentation associated with hypoxia–ischemia-
induced cell death at 48 h post-insult. Quantiﬁcation of
this DNA fragmentation on ipsilateral side in Fig. 3B–I
revealed that LPS pre-treatment led to a substantial
overall increase in the number of TUNEL+ cells in the
ipsilateral hemisphere of C57BL/6 (p< 0.05), BALB/c
(p< 0.05), CD1 (p< 0.05) and FVB (p< 0.05)
background strains when compared to saline-treated
controls (Fig. 3B, C). TUNEL+ cell counts across the
diﬀerent individual brain regions revealed the highest
increase in TUNEL+ cells in the isocortex of C57BL6
(p< 0.05), 129SVJ (p< 0.05) and FVB (p< 0.01)
animals (Fig. 3D), hippocampus of C57BL/6 (p< 0.01),
CD1 (p< 0.05) and FVB (p< 0.001) mice (Fig. 3H)
and external capsule of C57BL/6 (p< 0.01), BALB/c
(p< 0.05) and FVB (p< 0.05) pups (Fig. 3I). This was
followed by the striatum of BALB/c (p< 0.05) and CD1
(p< 0.05) animals (Fig. 3E) and thalamus in CD1
(p< 0.05) and FVB (p< 0.05) mice (Fig. 3G). Pyriform
cortex was the least aﬀected forebrain region, showing
only a signiﬁcant increase in cell death in the FVB
(p< 0.01) background strain (Fig. 3F).
TUNEL+ cell density: treatment and interstrain meta-
analysis. The TUNEL+ density comparison between HI
+ LPS and HI alone in Fig. 3C–I revealed 24 instances
(out of 35 possible) of a signiﬁcant increase for HI
+ LPS vs. HI alone, compared to 18/35 for HI + LPS
vs. HI + SAL comparison. These diﬀerences did not
reach statistical signiﬁcance in a Chi-Square tests microglial activation and neuronal cell loss on the C57BL/6, 129SVJ,
al hippocampal sections of C57BL/6, 129SVJ, BALB/c, CD1 and FVB
aı¨ve animals, second row shows mice exposed to hypoxic–ischemic
AL), and lower row animals pre-treated with 0.6 lg LPS/g body weight
. 1. Note the lack of microglial activation in the naı¨ve group. The LPS-
uronal cell loss, when compared to saline-treated controls. However,
d injury score. Compared with animals not injected prior to hypoxia–
, C) as well as in most FVB ipsilateral brain regions (D–I). Interstrain
ad the highest levels of combined injury score, with signiﬁcance being
llis one-way analysis, followed by Dunn multiple comparison test (*for
HI alone, overhead bar for interstrain treatment comparison). Bar
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injection-associated increase in density of TUNEL+
dying cells compared with hypoxia–ischemia alone
across the entire ipsilateral forebrain hemisphere, in any
of the studied subregions.
As with tissue volume loss, with three exceptions
(Fig. 3E, G, I), signiﬁcant interstrain diﬀerences for
TUNEL+ density were only observed between the two
strain subgroups, in all three treatments (HI alone, HI
+ SAL, HI + LPS) – with CD1 and FVB in one, and
129SVJ, C57BL/6 and BALB/c in the other subgroup. In
the B strain subgroup, there was a highly signiﬁcant
diﬀerence in the number of strong inter-subgroup
diﬀerences for CD1 (1/63) and for FVB (23/63). In the A
subgroup, 129SVJ again displayed a signiﬁcantly higher
number of inter-subgroup diﬀerences vs. FVB and CD1
(19/42), than for C57BL/6 (5/42) or BALB/c (0/42)
(p< 0.001 for either, as above). Moreover, diﬀerences
for C57BL/6 vs. BALB/c also reach signiﬁcance level
(p= 0.021).
In terms of treatment – HI alone was associated with a
total of 5 signiﬁcant interstrain comparisons at 0.05 level
out of possible 42 across Fig. 1C–I. HI + SAL was
associated with six out of 42 and HI + LPS with 13 out
of 42. As in Fig. 1, the data suggested that treatment
with LPS is associated with a higher number of strong
diﬀerences in TUNEL+ density between strains, but in
the current case this just barely missed signiﬁcance
level (p= 0.053 in the initial Chi-Square test in a 2  3
matrix, p= 0.068 for the post hoc 2  2 comparison of
HI + LPS vs. HI + SAL).GFAP immunoreactivity occluded side
Astroglial activation following hypoxic–ischemic insult,
and pre-sensitization with LPS and to lesser extent with
saline, is associated with a strong increase in GFAP
immunoreactivity (GFAP-IR) shown in Figs. 4 and 5A,
focusing on ipsilateral and contralateral hippocampus,
respectively, and surrounding brain regions.
Quantiﬁcation of this GFAP-IR with OPTIMAS using
optical luminosity value (OLV) system (Figs. 4 and 5B–I)
revealed that LPS-mediated sensitization signiﬁcantly
increased astrocytic activation compared to the saline-
injected controls.
On the occluded side (Fig. 4C–D), the eﬀect was
present in four out of ﬁve strains, with the exception of
BALB/c animals (Figs. 4 and 5). The C57BL/6 (p< 0.05)3
Fig. 3. DNA fragmentation-associated cell death detected with TUNEL is in
strains. (A) TUNEL assay of 40-lm coronal hippocampal sections of C57B
ischemia. The upper row shows untreated naı¨ve animals, second row mice
injected 12 h earlier with saline (HI + SAL), and lower row animals pre-trea
prior to hypoxia–ischemia had no signiﬁcant impact, whereas LPS pre-trea
Overall eﬀect across all six brain regions, both in terms of strain (B) and trea
death was also present in 5/6 regions in the FVB, 3/6 in the C57BL/6 and CD
saline-treated controls. Comparison with HI alone demonstrated an even hig
animals showing no overall signiﬁcant increase in cell death (A), the isocor
+ SAL and HI + LPS vs. HI alone (D). Interstrain comparison revealed that F
to 129SVJ mice followed by CD1 animals. p< 0.05 for Kruskal–Wallis one-w
vs. HI + SAL, §for HI + LPS vs. HI alone, #for HI + SAL vs. HI alone, overand FVB (p< 0.05) strains were particularly aﬀected,
with a signiﬁcant impact not just overall (Fig. 4B, C), but
also in four out of six regions, including isocortex
(p< 0.05 and p< 0.05, respectively), hippocampus
(p< 0.05 and p< 0.01, respectively) and thalamus
(p< 0.01 and p< 0.01, respectively). The ipsilateral
striatum was also signiﬁcantly aﬀected in the C57BL/6
strain (p< 0.05), whereas FVB animals were also
particularly aﬀected in the external capsule (p< 0.05)
(Fig. 4E–J). Overall strong eﬀects were also observed in
the 129SVJ (p< 0.05) and CD1 (p< 0.01) strains
(Fig. 4B, C), but on the regional level these were only
signiﬁcant in the isocortex (p< 0.01), striatum
(p< 0.05) and thalamus (p< 0.01) of CD1 mice
(Fig. 4E, H–I) and isocortex (p< 0.05) and pyriform
cortex (p< 0.05) of 129SVJ animals (Fig. 4E–F).
Of all ﬁve assessed strains, C57BL/6 animals also
demonstrated that vehicle/saline administration followed
by hypoxia–ischemia increased ipsilateral GFAP-IR
(Fig. 4A–C), compared to the untreated hypoxia–
ischemia controls in this strain (p< 0.01). This eﬀect
was signiﬁcant overall (Fig. 4B, C) and in all subregions
except the thalamus (Fig. 4G), i.e. in the isocortex
(p< 0.05), pyriform cortex (p< 0.01), hippocampus
(p< 0.05), striatum (p< 0.01) and external capsule
(p< 0.01) regions (Fig. 4E–H, J). 129SVJ (p= 0.462),
BALB/c (p= 0.5134), CD1 (p= 0.616) and FVB
(p= 0.3233) backgrounds did not show this ipsilateral
eﬀect.
Ipsilateral GFAP-IR: treatment and interstrain meta-
analysis. Comparison of ipsilateral GFAP-IR between HI
+ LPS and HI alone, and HI + LPS vs. HI + SAL
in Fig. 4C–I revealed virtually identical results, with
16 instances (out of 35 possible) of a signiﬁcant
increase for HI + LPS vs. HI alone, and 17/35 for the
HI + LPS vs. HI + SAL comparison (p= 0.811 in Chi-
Square test).
143). With the exception of the striatum brain region in
BALB/c animals HI-treated (Fig. 4E), signiﬁcant interstrain
diﬀerences for ipsilateral GFAP-IR were again only
observed between the two strain subgroups, in all three
treatments (HI alone, HI + SAL, HI + LPS) – with CD1
and FVB in one, and 129SVJ, C57BL/6 and BALB/c in
the other subgroup. In the B strain subgroup, there was
a highly signiﬁcant diﬀerence in the number of
signiﬁcant inter-subgroup comparisons for CD1 (12/63)
and for FVB (46/63). In the A subgroup, 129SVJ andcreased in animals pre-treated with LPS across all assessed mouse
L/6, 129SVJ, BALB/c, CD1 and FVB strains 48 h following hypoxia–
exposed to hypoxic–ischemic insult alone (HI alone), third row those
ted with 0.6 lg LPS/g body weight (HI + LPS). Saline administration
tment resulted in substantial increase in TUNEL+ cell death. (B, C)
tment (C) comparison. (D–I) Signiﬁcantly increased LPS-induced cell
1, and in 2/6 brain regions of the BALB/c animals, when compared to
her LPS-mediated increase in TUNEL+ cell counts. Despite 129SVJ
tex was still signiﬁcantly aﬀected when comparing HI + LPS vs. HI
VB was the most signiﬁcantly aﬀected strain, especially in comparison
ay analysis, followed by Dunn multiple comparison test (*for HI + LPS
head bar for interstrain treatment comparison). Bar scale = 0.5 mm.
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subgroup diﬀerences vs. FVB and CD1 (28/42 and 22/42,
respectively), than BALB/c (8/42) (p< 0.002 for either, as
above). Diﬀerences for 129SVJ vs. C57BL/6 vs. BALB/c
in terms of GFAP-IR did not reach signiﬁcance level
(p= 0.182).
In terms of treatment – HI alone was associated with a
total of 23 signiﬁcant interstrain comparisons at 0.05 level
out of possible 42 across Fig. 1C–I. HI + SAL with was
similarly associated with 16 out of 42 and HI + LPS
with 19 out of 42. The overall results are fairly similar
(p= 0.307 in the initial Chi-Square test in a 2  3
matrix), excluding a speciﬁc eﬀect of injecting LPS or
saline on signiﬁcantly increasing ipsilateral interstrain
diﬀerences for GFAP-IR.GFAP immunoreactivity contralateral, non-occluded
side
Most of the signiﬁcant changes observed on the occluded
side were also present in the contralateral, non-occluded
forebrain hemisphere. In particular, a similar signiﬁcant
increase in GFAP-IR following saline injection was also
observed on the non-occluded, contralateral side of the
C57BL/6 strain (Fig. 5A–C). On the regional level
(Fig. 5D–F, H–I), a signiﬁcant increase following saline
injection was also observed in the isocortex (p< 0.001),
pyriform cortex (p< 0.01), hippocampus (p< 0.001),
striatum (p< 0.001) and external capsule (p< 0.001).
Interestingly, the discrete neuroanatomical localization
of increased GFAP-IR in the contralateral hemisphere
(shown in Fig. 5A) was only present in the mid-lateral
part of isocortex, pyriform cortex, hippocampus, striatum
and external capsule. This appeared to resemble the
distribution of the aﬀected, mostly medial cerebral artery
(MCA) territory on the occluded, ipsilateral side
(Fig. 4A). Animals from the other four strains, i.e.
129SVJ (p= 0.549), BALB/c (p= 0.1128), CD1
(p= 0.7871) and FVB (p= 0.936) animals did not
show contralateral diﬀerence between the HI alone and
HI + SAL littermates (Fig. 5B, C).
Contralateral GFAP-IR: treatment and interstrain
meta-analysis. Unlike the ipsilateral side, contralateral
GFAP-IR comparisons between HI + LPS and HI alone,
and HI + LPS vs. HI + SAL in Fig. 5C–I revealed highly
disparate results, with 17 instances (out of 35 possible)
of a signiﬁcant increase of interstrain diﬀerences for HI3
Fig. 4. LPS-mediated sensitization to neonatal hypoxia–ischemia induces a
forebrain hemisphere on the side with carotid occlusion. (A) Hippocampal se
CD1 and FVB naı¨ve animals (top row), only exposed to HI insult (second row
prior to hypoxia–ischemia (last row). Note the clear increase in GFAP-IR th
capsule in the saline pre-injected C57BL/6 animal (A). (B, C) Overall GFA
astrogliosis using OPTIMAS-assessment of GFAP-IR with optical luminosi
C57BL/6, 129SVJ, CD1 and FVB strains. C57BL/6 and FVB animals app
signiﬁcant increase (D–I). This eﬀect was also seen in 3/6 CD1 and 2/6 129S
demonstrated a clear signiﬁcant astroglial immunoreactivity for the FVB stra
treatments, and particularly with C57BL/6 and 129SVJ in terms of HI alone in
multiple comparison test (*for HI + LPS vs. HI + SAL, §for HI + LPS vs. HI al
comparison). Bar scale = 0.5 mm.+ LPS vs. HI alone, vs. just 5/35 for the HI + LPS vs.
HI + saline comparisons (p< 0.01 in Chi-Square test).
Unlike Figs. 1–4, the data for BALB/c and CD1 in
Fig. 5 also showed more frequent exceptions in terms of
signiﬁcant intra-group diﬀerences. These were fairly
numerous, with 7/42 for BALB/c, and 7/21 for CD1,
respectively. Thus, these strains no longer strictly
conformed to subgroup A and B. If only strain
diﬀerences between the predeﬁned subgroups were
assessed, there was however a highly signiﬁcant
diﬀerence for the B subgroup in the number of
signiﬁcant inter-subgroup comparisons for CD1 (5/63)
and for FVB (55/63), with a p< 0.01 in Chi-Square test.
In the A subgroup, all three strains – 129SVJ, C57BL/6
and BALB/c displayed a roughly similar number of inter-
subgroup diﬀerences vs. FVB and CD1 (22/42, 22/42,
and 15/42, respectively), with a p-value of 0.210 for the
initial Chi-Square test in a 2  3 matrix.
In terms of treatment – HI alone was associated with a
total of 16 signiﬁcant interstrain comparisons at 0.05 level
out of possible 42 across Fig. 1C–I. HI + SAL with was
similarly associated with 21/42 and HI + LPS with
23/42. The overall ratio of results are fairly similar
(p= 0.331 in the initial Chi-Square test in a 2  3
matrix), arguing against a speciﬁc eﬀect of injecting LPS
or saline on signiﬁcantly increasing interstrain
diﬀerences for contralateral GFAP-IR.DISCUSSION
Mouse strain and the extent of hypoxic–ischemic
damage
The current study shows the strain background
inﬂuencing the response to neonatal hypoxic–ischemic
insult in the absence and presence of LPS, the extent of
tissue volume loss and neural cell death and the level of
injury-associated inﬂammatory markers. Strain-based
susceptibility to hypoxia–ischemia was particularly low in
the 129SVJ and then in the C57BL/6 inbred strains.
BALB/c mice showed moderate, and CD1 and FVB
animals a strong response, which was frequently
particularly pronounced in the case of FVB.
Interestingly, in the case of GFAP-IR, higher levels were
already observed in the naı¨ve controls in the FVB strain,
and thus could contribute to higher GFAP-IR levels in
the HI alone group of this strain. We acknowledge that
the precise extent of the changes in GFAP-IR fromstrogliosis with increased GFAP-immunoreactivity (GFAP-IR) in the
ctions showing distribution of GFAP-IR in C57BL/6, 129SVJ, BALB/c,
), previously injected with saline (third row) or pre-exposed to LPS 12
e dorsoparietal isocortex, rostral hippocampus, striatum and external
P-IR per strain (B) and per treatment (C). (D–I) Quantiﬁcation of
ty values (OLV) showed a signiﬁcant, LPS-induced increase in the
eared most aﬀected, overall (B, C) and with 4/6 regions showing a
VJ brain regions, but not in the BALB/c strain. Interstrain comparison
in when compared to most strains in both HI + SAL and HI + LPS
jury. p< 0.05 for Kruskal–Wallis one-way analysis, followed by Dunn
one, #for HI + SAL vs. HI alone, overhead bar for interstrain treatment
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speciﬁcally addressed here and should be assessed in
a future study with naı¨ve animals serving as baseline.
For the purpose of the current study, the levels in the
HI alone group were set as the baseline for comparison
between strains, and for comparison with LPS
sensitization or saline injection, as a key purpose here
was to compare response in these two diﬀerent sets of
treatment. LPS pre-treatment sensitized all ﬁve strains
to hypoxia–ischemia but to a diﬀerent extent: FVB
animals showing most overall damage and injury marker
response, followed by CD1, C57BL/6 and 129SVJ.
BALB/c strain responded weakest to LPS – a signiﬁcant
eﬀect versus saline pre-injected controls was only
observed in some brain subregions for TUNEL+ cell
death (Fig. 3). Against the somewhat lower levels of HI
only littermates the LPS-pre-treated BALB/c animals
also showed signiﬁcance for brain injury score (Fig. 2),
but even here, there was no signiﬁcant HI + LPS/HI
alone eﬀect for tissue volume loss (Fig. 1) or for ipsi-
(Fig. 4) and contralateral (Fig. 5) astrogliosis. C57BL/6
and FVB strains had a discrete but signiﬁcant response
with pre-sensitization to injection with saline, and
C57BL/6, 129SVJ and CD1 mice also revealed
pronounced but localized contralateral astrogliosis.
Previous adult ischemia studies have demonstrated
cerebrovascular architecture variations between mouse
strains (Barone et al., 1993; Fujii et al., 1997; Maeda
et al., 1999; Beckmann, 2000). C57BL/6 mice have an
incompletely formed circle of Willis (Fujii et al., 1997;
Maeda et al., 1998) and a larger MCA territory supply than
129SVJ mice (Connolly et al., 1996), which can partially
explain observations of a larger brain infarct following
artery occlusion in the C57BL/6 strain (Connolly et al.,
1996). A study using unilateral carotid ligation in postnatal
day 12 CD1 and C57BL/6 mice also revealed that the
C57BL/6 background was less vulnerable both to brain
injury and seizures than the CD1 strain (Comi et al.,
2009). The acute hypoxia study in adult C57BL/6 and
CD1 mice also demonstrated a higher tolerance and sur-
vival in the C57BL/6 inbred strain (Zwemer et al., 2007).
To our knowledge the only other study to have looked at
the eﬀects of neonatal hypoxia–ischemia following unilat-
eral carotid ligation and 30 min hypoxia in multiple mouse
strains (Sheldon et al., 1998) revealed minimal brain
injury in 129SVJ mice, moderate damage in C57BL/6
and a particularly strong response in the CD1 strain.
All these results are generally corroborated in our
ﬁndings. Simply judging by average results, 129SVJ
showed the least damage, followed by C57BL/6, then
BALB/C and CD1, with FVB being, overall, the most-
aﬀected. However, almost all signiﬁcant interstrain
diﬀerences – with few exceptions – with 129SVJ,
C57BL/6 and BALB/c in one, and CD1 and FVB in the
other subgroup. This fragmentation into these two
subgroups also continued across all three treatments
(HI alone, HI + SAL, HI + LPS).
Generally, the ability to pick up a signiﬁcant diﬀerence
is a function of the size of the underlying eﬀect, intra-
group variability and sample size. Strong eﬀects will be
picked up directly in direct comparisons even withmoderate sample size, but more moderate eﬀects can
also have an impact on more or less frequent detection
of signiﬁcant diﬀerences against other, strongly
disparate strains. In the current study, diﬀerent strains
within each subgroup also showed clear diﬀerences
using the Chi-Square test, in the number of signiﬁcant
comparisons with strains of the opposite subgroup for
tissue-loss and most damage-associated markers.
Strains within subgroup A (129SVJ, C5BL/6, BALB/c)
exhibited signiﬁcant diﬀerences for loss of brain volume,
brain injury index, density of TUNEL+ cell death and
ipsilateral GFAP-IR, strains within subgroup B (CD1,
FVB) for TUNEL and ipsi- and contralateral GFAP-IR.
Inside each subgroup, 129SvJ and FVB occupied the
more extreme position, which resulted in more
signiﬁcant comparisons with strains of the opposite group.
Overall, these positions continued across all three
treatments (HI alone, HI + SAL, HI + LPS), diﬀerent
forebrain sub-regions and markers of brain damage.
Moreover, the same also held true with the more
general fragmentation into the two subgroups. This
could suggest the presence of generic low and high
responder backgrounds, although at present we cannot
exclude that this apparent sub-grouping is a random
feature that arose by chance, and there is a continuum
of possible responses. It will be interesting to see if
there are biochemical markers very early after neonatal
hypoxia–ischemia or in naı¨ve postnatal day 7 pups that
diﬀer between strains and whether they show the same
alignment into these two strain subgroups, and possibly,
the same interstrain fragmentation.Saline-stressor eﬀect in the diﬀerent strain
backgrounds
This study revealed a saline-mediated increased response in
ipsilateral combined injury score of FVB mice. The C57BL/6
strain showed enhanced astrogliosis on both occluded and
non-occluded hemispheres in the saline group. The saline
used in our experimental design was obtained from
veterinary sources as sterile intravenous infusion, arguing
against endotoxin contamination or infection, and instead
pointing to other, stress-associated factors.
Stressful events can cause short and/or long-term
behavioral and neurochemical adverse outcomes and
inﬂuence circulating and brain cytokine activity (Gibb
et al., 2008; Audet et al., 2010). Individual animals as well
as diﬀerent strains show diverse sensitivity to stress,
where BALB/c mice are highly stress reactive in compar-
ison to C57BL/6 (Anisman et al., 2001, 2008). Social
stress alone (plus saline), or in combination with acute
immune challenges increases production of plasma corti-
costerone in both strains. Additionally, vehicle-treated
C57BL/6 mice have higher interleukin-6 (IL-6) expression
than the corresponding BALB/c group, suggesting strain-
associated response to stress (Gibb et al., 2011). Simi-
larly, forced-swim stressor alone (plus vehicle) signiﬁ-
cantly raised corticosterone levels in both strains
(Connor et al., 1997).
Although LPS-mediated up-regulation of IL-1b and
tumor necrosis factor alpha (TNFa) was observed in
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Interestingly, the presence of swim-stressor attenuated
IL-1b and TNFa up-regulation in the BALB/c mice,
suggesting altered immune activation in BALB/c animals
when compared to the more normo-sensitive C57BL/6
(Browne et al., 2012). These ﬁndings suggest that in our
experimental design the stress of dam separation and
intraperitoneal administration of saline could aﬀect the
immune response, as seen in the assessment of
immune-associated markers for astrogliosis and micro-
glial activation of C57BL/6 and FVB strains respectively.
Interestingly, there was also a non-signiﬁcant increase
in brain damage in saline-treated BALB/c animals when
compared to hypoxia–ischemia alone mice, again sug-
gesting a moderate stress-associated eﬀector for this
strain.Strain impact on combined inﬂammation and
hypoxic–ischemic insults
Our study demonstrates strong LPS-mediated
sensitization to neonatal hypoxia–ischemia in the
C57BL/6, 129SVJ, CD1 and FVB strains. However, this
degree of sensitization varies, and the BALB/c strain
produced a reduced response. We have used one
single set of dose and timing only in this study, whereas
other studies have used diﬀerent protocols such as LPS
dose of 0.3 mg/kg 12 h prior to insult (Wang et al.,
2009). Therefore it is possible that the BALB/c response
to LPS would diﬀer with diﬀerent doses and/or time
courses. It is also possible that an increase in n numbers
may reduce variability associated with this model, and
improve signiﬁcance.
Hypoxia–ischemia triggers inﬂammatory response
and cytokine production. Pre-treatment of CD1 mice
with TNFa monoclonal antibody signiﬁcantly reduces
infarction following MCA occlusion (Yang et al., 1998).
BALB/c mice pre-treated with TNF receptor linked to poly-
ethylene glycol have smaller infarct compared to controls
(Nawashiro et al., 1997). These data suggest strain-
independent modulatory eﬀect of TNFa on ischemic-
induced brain damage. However, microglial synthesis of
TNFa within the focal and border zone of cerebral infarc-
tion is strain dependent. BALB/c mice have larger infarc-
tion with signiﬁcantly fewer TNFa-producing microglia in
comparison to C57BL/6 animals (Lambertsen et al.,
2002).
Although the additional extent of volume loss or
astrogliosis never reached signiﬁcance in BALB/c3
Fig. 5. Strain-speciﬁc appearance of contralateral astrogliosis in the no
Hippocampal sections showing distribution of GFAP-IR in C57BL/6, 129SVJ
insult (second row), previously injected with saline (third row) or pre-exposed t
in C57BL/6 animals shows an increase in contralateral astroglial activation in
sometimes more pronounced in LPS-treated mice (B, C). (D–I) OPTIMAS Qua
in C5BL/6 and CD1 strains, in the former for HI + SAL vs. HI alone and in latt
as in 5/6 and 4/6 brain regions, respectively (D–I). Interestingly, interstrain com
compared to C57BL/6 and 129SVJ mice across all three treatments – HI a
diﬀerence in contralateral GFAP-IR between the three treatments. p< 0.
comparison test (*for HI + LPS vs. HI + SAL, §for HI + LPS vs. HI alone,
comparison). Bar scale = 0.5 mm.animals pre-treated with LPS, our data do show LPS-
induced eﬀects for TUNEL+ cell death. In addition,
compared to HI alone as a surrogate control, they also
show eﬀects for the brain injury score. If a saline-
associated stressor is considered for this strain, and
therefore a comparison between LPS-treated and
hypoxia–ischemia alone treatments is performed, one
can see that LPS pre-sensitization then becomes
signiﬁcant, increasing combined microglial activation
and neuronal cell loss as well as TUNEL+ cell death
assessments.
Our results show that hypoxia–ischemia has a
minimal response eﬀect on 129SVJ animals. Despite a
substantial increase with LPS pre-treatment, the
response to the synergistic model was generally smaller
when compared to the other strains. Besides
cerebrovascular anatomical diﬀerences (Fujii et al.,
1997; Maeda et al., 1998; Beckmann, 2000), studies look-
ing at the 129SVJ strain immune proﬁle, have shown
defective inﬂammatory cell recruitment (White et al.,
2002; Hoover-Plow et al., 2008). C57BL/6 mice exhibit
the strongest response in total cell recruitment following
intraperitoneal administration of thioglycollate, followed
by BALB/c, CD1 and lastly 129SVJ mice (White et al.,
2002). Inﬂammatory stimulus in C57BL/6 and 129SVJ
animals revealed that 129SVJ had a lower number of
recruited leucocytes and macrophages (Hoover-Plow
et al., 2008). This reduced 129SVJ ability to recruit
macrophages was also shown in a model of Mycobac-
terium tuberculosis, where 129SVJ mice were signiﬁ-
cantly more susceptible than C57BL/6 animals (Medina
and North, 1998). Our data demonstrate diminished
response to hypoxia–ischemia in the 129SVJ animals.
Despite successful sensitization with LPS, the 129SVJ
immune response and brain damage was still smaller
than most of the other strains, suggesting background-
dependent alteration of immune cell recruitment might
be responsible for the 129SVJ strain resistance to hypox-
ia–ischemia.Hypoxia–ischemia-induced astrogliosis
In addition to increased GFAP-IR in the ipsilateral
hemisphere of the 4 strains strongly responding to LPS,
two of these strains – C57BL/6 and CD1 - also showed
a signiﬁcant contralateral response, which followed the
ipsilateral change. C57BL/6 animals had a substantial
increase in astroglial immunoreactivity in the saline-
treated controls, and CD1 mice had a strong bilateraln-occluded forebrain hemisphere following hypoxia–ischemia. (A)
, BALB/c, CD1 and FVB naı¨ve animals (top row), only exposed to HI
o LPS 12 prior to hypoxia–ischemia (last row). Distribution of GFAP-IR
the HI + SAL group when compared to HI alone. This increase was
ntiﬁcation of GFAP-IR showed signiﬁcant treatment-induced increase
er for HI + LPS vs. HI + SAL and HI alone, both overall (B, C) as well
parison revealed substantially higher GFAP-IR in FVB animals when
lone, HI + SAL, HI + LPS – however, FVB animals did not show a
05 for Kruskal–Wallis one-way analysis, followed by Dunn multiple
#for HI + SAL vs. HI alone, overhead bar for interstrain treatment
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Unilateral occlusion by itself is known to produce little to
no histological damage (Rice et al., 1981) and reduction
on cerebral perfusion (Silverstein et al., 1984). This is
likely a result of compensatory mechanisms by the
remaining major vessels: contralateral carotid and both
vertebral arteries. However, in the presence of hypoxia,
this compensatory mechanism is greatly reduced
(Silverstein et al., 1984).pH studies following hypoxic–is-
chemic insult demonstrated a biphasic acidotic shift,
where a ﬁrst pH decrease occurred during the ﬁrst
30 min following insult and was associated with the ipsilat-
eral area supplied by the MCA, whereas the second shift
(60–90 min) also included the adjoining anterior and pos-
terior arteries, these signiﬁcantly aﬀected the mid-lateral,
ipsilateral isocortex, striatum, hippocampus and thalamus
(Kendall et al., 2012). With the current 30 min of hypoxia–
ischemia, our data concur with the most aﬀected area
being supplied by the MCA.
Although some acidosis occurs in the contralateral
hemisphere following hypoxia–ischemia, this is primarily
present in the areas directly adjacent to the ipsilateral
territory, i.e. the anterior (Tuor et al., 1993; Kendall
et al., 2012) and posterior cerebral arteries (Kendall
et al., 2012). Signiﬁcantly, this is not observed, at least
in short-term period, in the contralateral MCA, arguing
against the currently observed pattern of contralateral
astrogliosis being a direct result of hypoxia–ischemia. It
may be a result of homotypic aﬀerent and eﬀerent projec-
tions from roughly the same areas in one cortical hemi-
sphere to another, i.e. damage on ipsilateral side
leading to secondary response on the contralateral side,
as seen in rats (Moumdjian et al., 1991), and that in mice,
the C57BL/6 and CD1 strains are particularly susceptible.
Additionally, we have observed an increased level of
GFAP-IR in the FVB naı¨ve strain, which could
potentially have an eﬀect in the higher response
observed in this particular strain, and therefore future
studies should also include assessment of naı¨ve
animals as baseline response.
C57BL/6 as the optimal strain in combined
inﬂammation and hypoxia–ischemia
C57BL/6 and 129SVJ are the most used parent strains in
the creation of transgenic mice. Our data show that both
strains have minimal response to hypoxia–ischemia.
However, C57BL/6 animals have a higher degree of
brain injury following LPS pre-treatment compared to
129SVJ animals. This is in concordance with previous
ﬁndings, where C57BL/6 animals showed a larger
vascularised area supplied by the MCA (Maeda et al.,
1998). Additionally, 129SVJ mice have reduced ability to
recruit immune cells (White et al., 2002; Hoover-Plow
et al., 2008) and produce TNFa cytokine (Lambertsen
et al., 2002). This makes the use of the 129SVJ strain less
than desirable in our model of LPS sensitization to hypox-
ia–ischemia. BALB/c animals, although responsive to
LPS sensitization, only showed a mild non-signiﬁcant
increase in damage. Additionally, there was a baseline
response to hypoxia–ischemia, thus making this strain
less than ideal for the purpose of LPS-mediated sensitiza-tion in order to elicit brain injury. This same principle
excludes both CD1 and FVB animals, as brain damage
following hypoxia–ischemia was substantial in both
strains. C57BL/6 is the most well characterized isogenic
strain, allowing better understanding of the response to
diﬀerent stimuli, and demonstrated a robust response to
LPS sensitization. This strain would allow a clear compar-
ison between LPS and saline groups, with the added ben-
eﬁt of non-sensitivity to the moderate 30 min 8% oxygen
hypoxia–ischemia.Conclusion
Both cerebral blood vascularity and immune sensitivity
are known factors aﬀecting response to brain injury and
appear to be strain-dependent in both the hypoxia–
ischemia and in the inﬂammation-sensitization to
hypoxia–ischemia models, with robust FVB and CD1
and moderate BALB/c response in both types of insult.
The C57BL/6 and 129SVJ inbred strains appear
particularly resistance to hypoxia–ischemia alone.
However, LPS proved successful in sensitizing both
strains. C5BL/6 and FVB mice showed a saline-
mediated increase in inﬂammatory markers, possibly as
a result of stress-associated activation of the immune
system, indicating a need for proper consideration of
controls when choosing a study design.
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